Haro Josep Maria, Arbabzadeh-Bouchez Saena, Brugha Traolach S, de Girolamo Giovanni, Guyer Margaret E, Jin Robert, Lepine Jean Pierre, Mazzi Fausto, Reneses Blanca, Vilagut Gemma, Sampson Nancy A, Kessler Ronald C
Int J Methods Psychiatr Res. 2006;15(4):167-80. doi: 10.1002/mpr.196.
The DSM-IV diagnoses generated by the fully structured lay-administered Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) in the WHO World Mental Health (WMH) surveys were compared to diagnoses based on follow-up interviews with the clinician-administered non-patient edition of the Structured Clinical Interview for DSM-IV (SCID) in probability subsamples of the WMH surveys in France, Italy, Spain, and the US. CIDI cases were oversampled. The clinical reappraisal samples were weighted to adjust for this oversampling. Separate samples were assessed for lifetime and 12-month prevalence. Moderate to good individual-level CIDI-SCID concordance was found for lifetime prevalence estimates of most disorders. The area under the ROC curve (AUC, a measure of classification accuracy that is not influenced by disorder prevalence) was 0.76 for the dichotomous classification of having any of the lifetime DSM-IV anxiety, mood and substance disorders assessed in the surveys and in the range 0.62-0.93 for individual disorders, with an inter-quartile range (IQR) of 0.71-0.86. Concordance increased when CIDI symptom-level data were added to predict SCID diagnoses in logistic regression equations. AUC for individual disorders in these equations was in the range 0.74-0.99, with an IQR of 0.87-0.96. CIDI lifetime prevalence estimates were generally conservative relative to SCID estimates. CIDI-SCID concordance for 12-month prevalence estimates could be studied powerfully only for two disorder classes, any anxiety disorder (AUC = 0.88) and any mood disorder (AUC = 0.83). As with lifetime prevalence, 12-month concordance improved when CIDI symptom-level data were added to predict SCID diagnoses. CIDI 12-month prevalence estimates were unbiased relative to SCID estimates. The validity of the CIDI is likely to be under-estimated in these comparisons due to the fact that the reliability of the SCID diagnoses, which is presumably less than perfect, sets a ceiling on maximum CIDI-SCID concordance.
在世界卫生组织世界心理健康(WMH)调查中,将通过完全结构化的由外行人管理的复合国际诊断访谈第3.0版(CIDI 3.0)生成的《精神疾病诊断与统计手册》第四版(DSM-IV)诊断结果,与在法国、意大利、西班牙和美国的WMH调查概率子样本中,基于对使用DSM-IV临床定式访谈非患者版(SCID)进行的临床医生随访访谈得出的诊断结果进行了比较。CIDI病例进行了过采样。对临床重新评估样本进行加权,以调整这种过采样情况。对单独的样本评估了终生患病率和12个月患病率。对于大多数疾病的终生患病率估计,发现个体层面CIDI与SCID的一致性为中等至良好。对于在调查中评估的任何终生DSM-IV焦虑症、情绪障碍和物质使用障碍的二分分类,ROC曲线下面积(AUC,一种不受疾病患病率影响的分类准确性度量)为0.76,对于个体疾病,AUC在0.62 - 0.93范围内,四分位间距(IQR)为0.71 - 0.86。当在逻辑回归方程中添加CIDI症状水平数据以预测SCID诊断时,一致性增加。这些方程中个体疾病的AUC在0.74 - 0.99范围内,IQR为0.87 - 0.96。相对于SCID估计,CIDI终生患病率估计通常较为保守。仅针对两类疾病(任何焦虑症(AUC = 0.88)和任何情绪障碍(AUC = 0.83))才能有力地研究CIDI与SCID在12个月患病率估计方面的一致性。与终生患病率一样,当添加CIDI症状水平数据以预测SCID诊断时,12个月的一致性有所改善。相对于SCID估计,CIDI 12个月患病率估计无偏差。由于SCID诊断的可靠性可能并非完美无缺,这为CIDI与SCID的最大一致性设定了上限,因此在这些比较中,CIDI的有效性可能被低估。